Bridgefront Capital’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $385K | Buy |
+42,979
| New | +$385K | 0.1% | 350 |
|
|
2024
Q4 | – | Sell |
-33,126
| Closed | -$252K | – | 584 |
|
|
2024
Q3 | $252K | Buy |
33,126
+20,212
| +157% | +$154K | 0.1% | 385 |
|
|
2024
Q2 | $79.8K | Buy |
+12,914
| New | +$79.8K | 0.03% | 456 |
|
|
2023
Q4 | – | Sell |
-16,323
| Closed | -$116K | – | 382 |
|
|
2023
Q3 | $116K | Sell |
16,323
-3,979
| -20% | -$28.2K | 0.08% | 350 |
|
|
2023
Q2 | $143K | Buy |
+20,302
| New | +$143K | 0.08% | 407 |
|
|
2021
Q2 | – | Sell |
-20,028
| Closed | -$204K | – | 613 |
|
|
2021
Q1 | $204K | Buy |
+20,028
| New | +$204K | 0.06% | 583 |
|